Steven H Azurite Management... Net Worth

The estimated Net Worth of Steven H Azurite Management... is at least $2.55 Million dollars as of 17 November 2022. Steven Management owns over 122,820 units of Invacare stock worth over $2,419,054 and over the last 2 years Steven sold IVC stock worth over $127,152.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Steven Management IVC stock SEC Form 4 insiders trading

Steven has made over 3 trades of the Invacare stock since 2022, according to the Form 4 filled with the SEC. Most recently Steven sold 122,820 units of IVC stock worth $47,900 on 17 November 2022.

The largest trade Steven's ever made was selling 158,505 units of Invacare stock on 14 November 2022 worth over $79,253. On average, Steven trades about 143,775 units every 50 days since 2022. As of 17 November 2022 Steven still owns at least 3,665,233 units of Invacare stock.

You can see the complete history of Steven Management stock trades at the bottom of the page.

Insiders trading at Invacare

Over the last 21 years, insiders at Invacare have traded over $3,551,958 worth of Invacare stock and bought 391,450 units worth $2,325,949 . The most active insiders traders include Edward F Crawford, Aaron Malachi Iii Mixon und Steven H Azurite Management.... On average, Invacare executives and independent directors trade stock every 52 days with the average trade being worth of $10,700. The most recent stock trade was executed by Steven H Azurite Management... on 17 November 2022, trading 122,820 units of IVC stock currently worth $47,900.

What does Invacare do?

Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the Company designs, manufactures, and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The Company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The Company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers. The Company sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, distributors and government health services in North America, Europe and Asia Pacific.

Complete history of Steven Management stock trades at Invacare

Invacare executives and stock owners

Invacare executives and other stock owners filed with the SEC include:

• Matthew Monaghan,
  Chairman of the Board, President, Chief Executive Officer
• Kathleen Leneghan,
  Chief Financial Officer, Senior Vice President
• Matthew E. Monaghan,
  Chairman, Pres & CEO
• Anthony LaPlaca,
  Senior Vice President, General Counsel, Secretary
• Ralf Ledda,
  Senior Vice President, General Manager - Europe, Middle East and Africa
• Anthony C. LaPlaca,
  Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec.
• Kathleen P. Leneghan,
  Sr. VP & CFO
• Joost Beltman,
  Sr. VP & GM of North America
• Angela Goodwin,
  Sr. VP & Chief Information Technology Officer
• C. Martin Harris,
  Lead Independent Director
• Baiju Shah,
  Independent Director
• Clifford Nastas,
  Independent Director
• Susan Alexander,
  Independent Director
• Marc Gibeley,
  Independent Director
• Diana Ferguson,
  Independent Director
• Petra Danielsohn-Weil,
  Independent Director
• Julie Beck,
  Independent Director
• Lois Lee,
  Director, Treasury and Investor Relations
• Geoffrey P. Purtill,
  Sr. VP and GM of EMEA & APAC
• Geoffrey Purtill,
  Sr. VP and GM of EMEA & Asia Pacific
• Rick A. Cassiday,
  Sr. VP & Chief HR Officer
• Lois Lee CTP,
  Director of Treasury, Investor Relations & Corp. Comm.
• Stephanie L. Fehr,
  Director
• Steven H Azurite Management...,
  
• Rick A. Cassiday,
  SVP, Human Resources
• Michael J Merriman,
  Director
• Robert K Gudbranson,
  Senior VP and CFO
• Patricia A. Stumpp,
  Senior VP, Human Resources
• Dale C La Porte,
  Director
• Dean J. Childers,
  SVP & GM, North America
• Barbara W. Bodem,
  Director
• Darcie Karol,
  SVP, Human Resources
• Joost Beltman,
  Sr. VP and GM, North America
• Angie Goodwin,
  Chief Information Officer
• Joseph S Usaj,
  Senior VP - Human Resources
• Ellen O. Tauscher,
  Director
• John Remmers,
  Sr. VP Global Supply Chain&Eng
• Aaron Malachi Iii Mixon,
  Chairman and CEO
• Gerald B Blouch,
  President and COO
• Bridget A Miller,
  Vice President & Gen. Counsel
• Louis F J Slangen,
  Senior V.P.-Sales & Marketing
• Kenneth Sparrow,
  President-Invacare Europe
• Bernadine Healy,
  Director
• Diane J Davie,
  Senior VP - Human Resources
• James C Boland,
  Director
• Michael F Delaney,
  Director
• James L Jones,
  Director
• Danny O Driscoll,
  Managing Dir./Asia Pacific
• Joseph B Ii Richey,
  Senior Vice President
• William M Weber,
  Director
• Gregory C Thompson,
  Senior V.P. & CFO
• Dan T Iii Moore,
  Director
• Charles S. Robb,
  Director
• Carl E. Will,
  Sen. VP, Global Commercial Ops
• Franz Krammer,
  Mg. Dir. - Invacare Europe
• John Kasich,
  Director
• Whitney Evans,
  Director
• Neal J Curran,
  V.P.-Engineering & Prod. Dev.
• Matthew T Mullarkey,
  Vice President of Operations
• Gordon Sutherland,
  SVP & GM, EMEA
• Kempner Capital Management ...,
  
• Geoffrey Purtill,
  President and CEO
• Aron I Schwartz,
  Director
• Edward F Crawford,
  Director
• Steven H Rosen,
  Director